Antiretroviral Therapy Switching Among People with HIV in the United States is not Uncommon Despite Virologic Suppression: An OPERA Cohort Study

In this large, contemporary US cohort, ART regimen switching was somewhat common and most frequently occurred among virologically suppressed PWH. These real-world findings on the incidence and patterns of virologically suppressed switches provide insight into new trends in treatment optimization and the need for new therapeutic options.

Authors

Institutions

Publication Details

Journal
Infectious Diseases and Therapy
Published
2026-03-22
DOI
https://doi.org/10.1007/s40121-026-01334-3
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antiretroviral Therapy Switching Among People with HIV in the United States is not Uncommon Despite Virologic Suppression: An OPERA Cohort Study

Michael Sension, Jennifer S Fusco, Michael D. Osterman, Gerald Pierone et al.
Infectious Diseases and Therapy
HIV/AIDS drug development and treatment
article

Antiretroviral Therapy Switching Among People with HIV in the United States is not Uncommon Despite Virologic Suppression: An OPERA Cohort Study

Michael Sension, Jennifer S Fusco, Michael D. Osterman, Gerald Pierone, Laurence Brunet, Girish Prajapati, Gregory Fusco, Sean P. Fleming, Ricky K. Hsu, Karam Mounzer, Anthony M. Mills
article en

Abstract

In this large, contemporary US cohort, ART regimen switching was somewhat common and most frequently occurred among virologically suppressed PWH. These real-world findings on the incidence and patterns of virologically suppressed switches provide insight into new trends in treatment optimization and the need for new therapeutic options.

Infectious Diseases and Therapy
Meridian Institute (US), Merck & Co., Inc., Rahway, NJ, USA (United States) (US), AIDS Healthcare Foundation (US), Fayetteville State University (US), NYU Langone Health (US), Oyster Point Family Health Center (US), International Myeloma Foundation (US), Philadelphia Fight (US)
Good health and well-being
Openalex Percentile: Top 15%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.